You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study

Article metrics

Article menu

Download PDFPDF

XML
Spondyloarthritis
Original article
Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study

 

Online download statistics by month:

Online download statistics by month: June 2019 to March 2023

AbstractFullPdf
Jun 201914414161
Jul 201914114156
Aug 2019908835
Sep 2019929029
Oct 2019655722
Nov 2019616117
Dec 2019575719
Jan 2020605428
Feb 202040388
Mar 202031297
Apr 2020252320
May 2020434322
Jun 2020292915
Jul 202036366
Aug 202028299
Sep 2020615215
Oct 2020545417
Nov 2020424114
Dec 2020393713
Jan 2021525131
Feb 202124214
Mar 2021454216
Apr 2021444412
May 2021433714
Jun 202130288
Jul 2021494913
Aug 2021282817
Sep 2021323211
Oct 2021373730
Nov 2021423920
Dec 2021342511
Jan 202222218
Feb 202233349
Mar 202244427
Apr 202244389
May 2022817412
Jun 2022656311
Jul 202274559
Aug 202259558
Sep 2022707010
Oct 2022585518
Nov 2022343411
Dec 2022434210
Jan 2023384016
Feb 202349486
Total23122204744